Krystal Biotech, Inc. KRYS Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s finished goods?
- Krystal Biotech, Inc. (KRYS) reported finished goods of $12.36M in Q1 2026.
- How has Krystal Biotech, Inc.'s finished goods changed year-over-year?
- Krystal Biotech, Inc.'s finished goods increased by 109.5% year-over-year, from $5.9M to $12.36M.
- What is the long-term trend for Krystal Biotech, Inc.'s finished goods?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s finished goods has grown at a 285.4% compound annual growth rate (CAGR), from $627K to $9.31M.